share_log

Needham Reiterates Hold on ResMed

Benzinga ·  Sep 18 18:06

Needham analyst Mike Matson reiterates ResMed (NYSE:RMD) with a Hold.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment